LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West Africa.

    Fink, Douglas L / Oladele, David A / Slack, Abigail J / Odubela, Oluwatosin / Musari-Martins, Tomilola / Okechukwu, Adaobi / Adetayo, Kemi / Opaneye, Sola / Abubakar, Rufai / David, Agatha / Cai, James / Quaderi, Shumonta / Abubakar, Ibrahim / Ezechi, Oliver / Hurst, John R / Lipman, Marc / Salako, Babatunde

    AIDS (London, England)

    2022  Band 36, Heft 14, Seite(n) 1987–1995

    Abstract: Objective: HIV and tuberculosis (TB) are risk factors for non-communicable chronic lung disease (CLD). Despite the high prevalence of these infections in West Africa, there are no studies that compare CLD between people with HIV and HIV-negative ... ...

    Abstract Objective: HIV and tuberculosis (TB) are risk factors for non-communicable chronic lung disease (CLD). Despite the high prevalence of these infections in West Africa, there are no studies that compare CLD between people with HIV and HIV-negative populations in this setting. This study sought to quantify the contribution of HIV and TB infection in addition to conventional CLD risk factors, such as tobacco and biofuel exposure, to CLD in urban West Africa.
    Design: A multi-centre cross-sectional study was conducted in three community clinics in Lagos, Nigeria between 2018 and 2019.
    Methods: Spirometry, questionnaires and clinical records were used to estimate prevalence of CLD and association with risk factors.
    Results: In total, 148 HIV-negative individuals and 170 HIV-positive individuals completed the study. Current cigarette (11 of 318, 3.5%) and lifetime domestic biofuel (6 of 318, 1.8%) exposures were low. Airway obstruction (33 of 170, 19.4% vs. 12 of 148, 8.1%, P  = 0.004) and CLD (73 of 170, 42.9% vs. 34 of 148, 23%, P  < 0.0001) were more prevalent in people with HIV compared with the HIV-negative group. HIV infection [odds ratio 2.35 (1.33, 4.17), P  = 0.003] and history of TB [odds ratio 2.09 (1.04, 4.20), P  = 0.038] were independently associated with increased risk of CLD.
    Conclusion: HIV and TB far outweigh conventional risk factors, including tobacco and domestic biofuel exposure, as drivers of non-communicable CLD in urban West Africa. Current global policy for CLD may have limited impact on CLD in this setting. Enhanced prevention, diagnosis and management strategies for incident HIV and TB infections are likely to have a significant impact on long-term lung health in sub-Saharan Africa.
    Mesh-Begriff(e) Humans ; HIV Infections/complications ; HIV Infections/epidemiology ; Cross-Sectional Studies ; Biofuels ; Nigeria/epidemiology ; Tuberculosis/complications ; Tuberculosis/epidemiology ; Lung Diseases/epidemiology ; Risk Factors ; Prevalence ; Africa, Western
    Chemische Substanzen Biofuels
    Sprache Englisch
    Erscheinungsdatum 2022-08-18
    Erscheinungsland England
    Dokumenttyp Observational Study ; Multicenter Study ; Journal Article
    ZDB-ID 639076-6
    ISSN 1473-5571 ; 0269-9370 ; 1350-2840
    ISSN (online) 1473-5571
    ISSN 0269-9370 ; 1350-2840
    DOI 10.1097/QAD.0000000000003360
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.

    González-Calle, Verónica / Slack, Abigail / Keane, Niamh / Luft, Susan / Pearce, Kathryn E / Ketterling, Rhett P / Jain, Tania / Chirackal, Sintosebastian / Reeder, Craig / Mikhael, Joseph / Noel, Pierre / Mayo, Angela / Adams, Roberta H / Ahmann, Gregory / Braggio, Esteban / Stewart, A Keith / Bergsagel, P Leif / Van Wier, Scott A / Fonseca, Rafael

    Annals of hematology

    2018  Band 97, Heft 8, Seite(n) 1453–1462

    Abstract: The International Myeloma Working Group has proposed the Revised International Staging System (R-ISS) for risk stratification of multiple myeloma (MM) patients. There are a limited number of studies that have validated this risk model in the autologous ... ...

    Abstract The International Myeloma Working Group has proposed the Revised International Staging System (R-ISS) for risk stratification of multiple myeloma (MM) patients. There are a limited number of studies that have validated this risk model in the autologous stem cell transplant (ASCT) setting. In this retrospective study, we evaluated the applicability and value for predicting survival of the R-ISS model in 134 MM patients treated with new agents and ASCT at the Mayo Clinic in Arizona and the University Hospital of Salamanca in Spain. The patients were reclassified at diagnosis according to the R-ISS: 44 patients (33%) had stage I, 75 (56%) had stage II, and 15 (11%) had stage III. After a median follow-up of 60 months, R-ISS assessed at diagnosis was an independent predictor for overall survival (OS) after ASCT, with median OS not reached, 111 and 37 months for R-ISS I, II and III, respectively (P < 0.001). We also found that patients belonging to R-ISS II and having high-risk chromosomal abnormalities (CA) had a significant shorter median OS than those with R-ISS II without CA: 70 vs. 111 months, respectively. Therefore, this study lends further support for the R-ISS as a reliable prognostic tool for estimating survival in transplant myeloma patients and suggests the importance of high-risk CA in the R-ISS II group.
    Mesh-Begriff(e) Adult ; Aged ; Biomarkers ; Female ; Hematopoietic Stem Cell Transplantation ; Humans ; Induction Chemotherapy ; Maintenance Chemotherapy ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Multiple Myeloma/pathology ; Multiple Myeloma/therapy ; Neoplasm Staging/methods ; Prognosis ; Retrospective Studies ; Survival Analysis ; Transplantation, Autologous ; Treatment Outcome
    Chemische Substanzen Biomarkers
    Sprache Englisch
    Erscheinungsdatum 2018-04-06
    Erscheinungsland Germany
    Dokumenttyp Journal Article
    ZDB-ID 1064950-5
    ISSN 1432-0584 ; 0939-5555 ; 0945-8077
    ISSN (online) 1432-0584
    ISSN 0939-5555 ; 0945-8077
    DOI 10.1007/s00277-018-3316-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang